Cargando…

Tolerability and acceptability of electroporation during a Phase 1 vaccine trial at two sites in Uganda and Rwanda

Detalles Bibliográficos
Autores principales: Mpendo, J, Bayingana, R, Nanvubya, A, Karita, E, Ssetaala, A, Kiwanuka, N, Lehrman, J, Schmidt, C, Hannaman, D, Allen, S, Fast, P
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3441912/
http://dx.doi.org/10.1186/1742-4690-9-S2-P126
_version_ 1782243403437703168
author Mpendo, J
Bayingana, R
Nanvubya, A
Karita, E
Ssetaala, A
Kiwanuka, N
Lehrman, J
Schmidt, C
Hannaman, D
Allen, S
Fast, P
author_facet Mpendo, J
Bayingana, R
Nanvubya, A
Karita, E
Ssetaala, A
Kiwanuka, N
Lehrman, J
Schmidt, C
Hannaman, D
Allen, S
Fast, P
author_sort Mpendo, J
collection PubMed
description
format Online
Article
Text
id pubmed-3441912
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-34419122012-09-18 Tolerability and acceptability of electroporation during a Phase 1 vaccine trial at two sites in Uganda and Rwanda Mpendo, J Bayingana, R Nanvubya, A Karita, E Ssetaala, A Kiwanuka, N Lehrman, J Schmidt, C Hannaman, D Allen, S Fast, P Retrovirology Poster Presentation BioMed Central 2012-09-13 /pmc/articles/PMC3441912/ http://dx.doi.org/10.1186/1742-4690-9-S2-P126 Text en Copyright ©2012 Mpendo et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Poster Presentation
Mpendo, J
Bayingana, R
Nanvubya, A
Karita, E
Ssetaala, A
Kiwanuka, N
Lehrman, J
Schmidt, C
Hannaman, D
Allen, S
Fast, P
Tolerability and acceptability of electroporation during a Phase 1 vaccine trial at two sites in Uganda and Rwanda
title Tolerability and acceptability of electroporation during a Phase 1 vaccine trial at two sites in Uganda and Rwanda
title_full Tolerability and acceptability of electroporation during a Phase 1 vaccine trial at two sites in Uganda and Rwanda
title_fullStr Tolerability and acceptability of electroporation during a Phase 1 vaccine trial at two sites in Uganda and Rwanda
title_full_unstemmed Tolerability and acceptability of electroporation during a Phase 1 vaccine trial at two sites in Uganda and Rwanda
title_short Tolerability and acceptability of electroporation during a Phase 1 vaccine trial at two sites in Uganda and Rwanda
title_sort tolerability and acceptability of electroporation during a phase 1 vaccine trial at two sites in uganda and rwanda
topic Poster Presentation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3441912/
http://dx.doi.org/10.1186/1742-4690-9-S2-P126
work_keys_str_mv AT mpendoj tolerabilityandacceptabilityofelectroporationduringaphase1vaccinetrialattwositesinugandaandrwanda
AT bayinganar tolerabilityandacceptabilityofelectroporationduringaphase1vaccinetrialattwositesinugandaandrwanda
AT nanvubyaa tolerabilityandacceptabilityofelectroporationduringaphase1vaccinetrialattwositesinugandaandrwanda
AT karitae tolerabilityandacceptabilityofelectroporationduringaphase1vaccinetrialattwositesinugandaandrwanda
AT ssetaalaa tolerabilityandacceptabilityofelectroporationduringaphase1vaccinetrialattwositesinugandaandrwanda
AT kiwanukan tolerabilityandacceptabilityofelectroporationduringaphase1vaccinetrialattwositesinugandaandrwanda
AT lehrmanj tolerabilityandacceptabilityofelectroporationduringaphase1vaccinetrialattwositesinugandaandrwanda
AT schmidtc tolerabilityandacceptabilityofelectroporationduringaphase1vaccinetrialattwositesinugandaandrwanda
AT hannamand tolerabilityandacceptabilityofelectroporationduringaphase1vaccinetrialattwositesinugandaandrwanda
AT allens tolerabilityandacceptabilityofelectroporationduringaphase1vaccinetrialattwositesinugandaandrwanda
AT fastp tolerabilityandacceptabilityofelectroporationduringaphase1vaccinetrialattwositesinugandaandrwanda